Antitubercular agent-38

• Description:

  Antitubercular agent-38 is an orally active Benzothiazinones (BTZs) derivate, with potent antituberculosis activity. Antitubercular agent-38 exhibits low cardiac toxicity, low cell cytotoxicity[1].

• UNSPSC:

  12352005

• Target:

  Bacterial

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/antitubercular-agent-38.html

• Solubility:

  10 mM in DMSO

• Smiles:

  FC(F)(F)C1=CC([N+]([O-])=O)=C2C(C(N=C(N3CCN(N(C4CCC(C)(C)CC4)C)CC3)S2)=O)=C1

• Molecular Formula:

  C22H28F3N5O3S

• Molecular Weight:

  499.55

• References & Citations:

  [1]Wang A, et al. Design, synthesis and antitubercular activity of novel N- (amino) piperazinyl benzothiazinones with improved safety. Eur J Med Chem. 2023 Oct 5;258:115545.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [9007-83-4]